Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05955170
Title Tucatinib in Combination With Oral Etoposide andTrastuzumab in Patients With Metastatic HER2+ Breast Cancer (TUC-TOC)
Acronym TUC-TOC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut Curie
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA


No variant requirements are available.